Powered Hystera cutter
The highlight of this product is the completion of tissue resection surgery in the abdominal tissue bag, successfully solving the problem of surgical residues that cannot be completely removed using traditional surgical instruments, and avoiding the risk of iatrogenic tumor implantation and metastasis in the pelvic cavity. At the same time, it has a significant effect on reducing complications and recovery time of traditional surgery.
Surgical risks of uterine fibroids
The US Food and Drug Administration (FDA) issued a 2014 warning in April to discourage doctors from using hysterectomy devices to remove uterine fibroids, as this may spread the tumor into the abdominal cavity. Shortly thereafter, Johnson&Johnson withdrew its laparoscopic uterine pulverizer from the market. In November of the same year, the FDA strengthened its warning, stating that "the FDA warns against the use of laparoscopic uterine shredders in hysterectomy or myomectomy for the treatment of uterine fibroids
According to the FDA, tens of thousands of people use these devices for surgery every year, and 1/350 of women may be at risk of cancer spreading due to their undiagnosed cancer that may be contagious. They usually involve the kidneys or spleen, but the complications of disease transmission are the same.
These devices may also cause cancer to spread to benign tissues throughout the abdominal cavity, where they can grow on other organs, causing pain, intestinal obstruction, and infection.
